Images
Participants
Contact
United Press International publishes an extensive article about the study headed by Patrick Aloy, ICREA researcher and leader of the Structural Bioinformatics and Network Biology Lab at IRB Barcelona.
Published in Cancer Research Journal, the study reveals a new way to fight drug resistance in the treatment of breast cancer through bioinformatics.
Link to UPI
Other media mentions:
Link to La Vanguardia
Link to Agencia SINC
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
